HR-4609-119
Referred to the House Committee on Financial Services.
Sponsored by Gary Palmer (R-AL)
What it does
This bill would extend the expiration date of the Defense Production Act of 1950 (DPA) from September 30, 2025, to September 30, 2031 — a six-year extension. The DPA gives the executive branch broad authority to direct private industry to prioritize government contracts, allocate scarce materials, and expand domestic production capacity for national defense and emergency purposes. The bill makes no other changes to the Act's existing authorities or limitations.
Who benefits
The federal government and executive branch agencies (including the Department of Defense and FEMA) that rely on DPA authority to direct industrial production. Defense contractors and manufacturers who receive prioritized government orders. Domestic industries in sectors deemed critical — such as semiconductors, pharmaceuticals, and rare earth materials — that may receive government support or contracts under DPA. Communities dependent on defense manufacturing employment. Emergency management agencies that use DPA authority during natural disasters and public health emergencies.
Who is hurt
Private companies that could be compelled to accept government production orders over more profitable commercial contracts, potentially disrupting their business planning. Businesses in supply chains affected by government-directed material allocations, which may face shortages or price distortions. Foreign manufacturers and trading partners who compete with domestically prioritized producers. Taxpayers who may bear costs if DPA authority is used to fund industrial expansion or subsidize production. Companies that prefer market-based allocation of resources over government-directed production.
Supporters argue
Supporters argue that the DPA is a foundational tool for national security and emergency preparedness, with a track record spanning over 70 years — invoked during COVID-19 to accelerate vaccine production, ventilator manufacturing, and PPE supply. They contend that allowing the authority to lapse would create a dangerous gap in the government's ability to respond to supply chain crises, military needs, or future pandemics, and that a six-year extension provides the long-term certainty that defense industrial planning requires.
Opponents argue
Opponents argue that the DPA grants the executive branch sweeping, open-ended authority to intervene in private markets with limited congressional oversight, and that routine multi-year extensions allow that power to persist without meaningful reauthorization review. They contend that each extension is an opportunity to add accountability mechanisms, sunset specific authorities, or narrow the Act's scope — and that a clean six-year extension forfeits that leverage, leaving broad executive power over private industry unchecked until 2031.
Constitutional context
The DPA rests on Congress's Commerce Clause authority (Art. I, §8, cl. 3) and the Necessary and Proper Clause (Art. I, §8, cl. 18) to regulate economic activity in support of national defense. Post-Loper Bright (2024), courts now independently assess whether agency actions under the DPA fall within the statute's authorized scope, rather than deferring to executive branch interpretations — meaning expansive uses of DPA authority face heightened judicial scrutiny.
Checks and balances
The executive branch — primarily the President and designated agencies — gains continued authority to direct private industrial production; Congress retains oversight through appropriations, reporting requirements built into the existing DPA, and the ability to amend or repeal the Act before 2031.
Historical precedent
The Defense Production Act has been reauthorized repeatedly since 1950, most recently extended through September 30, 2025; similar clean reauthorization bills have passed with broad bipartisan support in prior Congresses.